Alopecia associated with zidovudine therapy

Area of Science:

• Dermatology
• Virology
• Pharmacology

Background:

• Alopecia is a known condition in patients with human immunodeficiency virus (HIV).
• Zidovudine, an antiretroviral medication, has been anecdotally reported to affect hair growth in HIV-infected individuals.
• The specific relationship between zidovudine and alopecia areata requires further investigation.

Observation:

• A 33-year-old male patient with HIV developed alopecia areata.
• The onset of alopecia areata coincided with the initiation of zidovudine therapy.
• The patient's hair loss condition showed improvement upon discontinuation of zidovudine.

Findings:

• Zidovudine therapy was associated with the development of alopecia areata in an HIV-infected patient.
• Cessation of zidovudine led to the reversal of alopecia areata.
• This case suggests a potential causal link between zidovudine and alopecia areata.

Implications:

• Clinicians should consider zidovudine as a potential trigger for alopecia areata in HIV patients.
• Monitoring for hair loss is recommended during zidovudine treatment.
• Further research is warranted to elucidate the mechanisms underlying zidovudine-induced alopecia.